The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity.
about
Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascade.Anilinoquinazoline inhibitors of the RET kinase domain-Elaboration of the 7-position.The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
P2860
The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The discovery of 2-substituted ...... with improved KDR selectivity.
@ast
The discovery of 2-substituted ...... with improved KDR selectivity.
@en
type
label
The discovery of 2-substituted ...... with improved KDR selectivity.
@ast
The discovery of 2-substituted ...... with improved KDR selectivity.
@en
prefLabel
The discovery of 2-substituted ...... with improved KDR selectivity.
@ast
The discovery of 2-substituted ...... with improved KDR selectivity.
@en
P2093
P2860
P1476
The discovery of 2-substituted ...... with improved KDR selectivity
@en
P2093
Alexandra I J Stowell
Allan M Jordan
Amanda J Lyons
Amanda J Watson
Andrew G Purkiss
Bohdan Waszkowycz
Donald J Ogilvie
Emily M Burns
Gemma V Hopkins
Graeme J Thomson
P2860
P356
10.1016/J.EJMECH.2016.01.039
P577
2016-01-29T00:00:00Z